Viropro Inc.
VPRO
Rank in Stocks
#34338
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Share Price
$0.00002
Last synced: 2026-11-06
Market Cap
$25.40K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Viropro Inc. (VPRO)
Category
Healthcare
EPS for Viropro Inc. (VPRO)
EPS as of September 2011 TTM: $0.00
According to Viropro Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2010 the company had an EPS of $-0.01, equal to its 2009 EPS of $-0.01.
EPS history for Viropro Inc. from 2003 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -58.00% |
| 2010 | $-0.01 | 0.00% |
| 2009 | $-0.01 | -80.00% |
| 2008 | $-0.05 | -37.50% |
| 2007 | $-0.08 | -55.56% |
| 2006 | $-0.18 | -21.74% |
| 2005 | $-0.23 | -17.86% |
| 2004 | $-0.28 | 13,233.33% |
| 2003 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -372,957.14% |
US
|
|
| $-7.07 | 168,233.33% |
US
|
|
| $-5.29 | 125,852.38% |
AU
|
|
| $12.88 | -306,769.05% |
BE
|
|
| $21.56 | -513,433.33% |
NL
|
Questions about Viropro Inc.'s earnings per share (EPS)
What is Viropro Inc.'s earnings per share (EPS)?
Viropro Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2011.
What was Viropro Inc.'s earnings per share (EPS) in 2010?
In 2010, Viropro Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2009.
How has Viropro Inc.'s earnings per share (EPS) changed since 2005?
From 2005 to 2010, Viropro Inc.'s earnings per share (EPS) was highest in 2010 ($-0.01) and lowest in 2005 ($-0.23).
How does Viropro Inc.'s earnings per share (EPS) compare with similar companies?
Viropro Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.